Man Dies After ‘Cow Virus’ Jumps to Human for First Time

A mysterious virus that scientists once believed could not infect humans has been detected in a patient who died in France, marking a troubling medical first as health officials investigate its sudden spread across Europe.

French authorities announced Thursday, October 22, that the Shamonda virus, previously found only in animals, had been identified in a severely immunocompromised patient receiving treatment for a serious illness at a hospital in Lyon. The patient died in early October, although investigators have not determined whether the infection caused or contributed to the death.

The discovery has caught the attention of European health officials, particularly because the virus only recently appeared on the continent after circulating for decades in parts of Africa and Asia.

According to France’s Ministry of Agriculture, the patient developed serious neurological complications before dying. Preliminary findings suggest those complications were very likely connected to the Shamonda infection, although additional testing is underway.

Investigators believe the patient may have contracted the virus through the bite of an infected midge, a tiny insect that feeds on blood. The suspected exposure occurred in eastern France, where the virus had been spreading among livestock during the spring and summer.

Shamonda was first identified in Nigeria during the 1960s and has primarily affected cattle, although infections have also been documented in sheep, goats and other animals. Until this year, the virus had never been detected in Europe or confirmed in a human patient.

That changed over the summer when farmers across several European countries began reporting unexplained illnesses among their cattle. Animals developed fevers, diarrhea, weakness and significant declines in milk production. Researchers eventually identified a Shamonda-type virus as a possible explanation for the emerging outbreak.

By October, the virus had been detected in farm animals across numerous European countries, including France, Germany, Switzerland, Belgium, Italy and Ireland.

Scientists are also examining whether unusually warm weather helped accelerate its spread. Researchers at France’s National Research Institute for Agriculture, Food and Environment have pointed to climatic conditions favorable to biting insects as a possible explanation for the virus’s rapid expansion.

The development raises broader concerns about the changing landscape of infectious diseases as rising temperatures influence insect populations and the environments in which they thrive. However, scientists have not established that climate change caused Shamonda’s arrival in Europe or the infection in France.

The case also highlights the importance of public-health research and international cooperation. French laboratories identified the emerging livestock virus using advanced genetic testing, while European disease specialists are now working to improve surveillance and determine whether additional human infections could occur.

For now, officials are urging caution rather than alarm.

The European Centre for Disease Prevention and Control confirmed that the French patient represents the first documented human infection. The agency is coordinating with French authorities and other European partners to better understand how the virus spreads and whether it presents a broader health concern.

French officials have emphasized that the patient had a severely weakened immune system, making the circumstances particularly unusual. They say no health risk to the general population has been identified based on current scientific evidence.

Still, the discovery leaves researchers with important unanswered questions about a virus that, until recently, was considered an animal-health problem.

As scientists continue investigating the patient’s death and the virus’s unexpected arrival in Europe, the case serves as another reminder of why monitoring emerging diseases, protecting vulnerable patients and investing in scientific research remain essential to public health.